Literature DB >> 9855605

Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation.

R W Powers1, R W Evans, A K Majors, J I Ojimba, R B Ness, W R Crombleholme, J M Roberts.   

Abstract

OBJECTIVE: We tested the hypothesis that the independent risk factor for atherosclerosis of increased plasma homocysteine concentration is associated with the pregnancy syndrome of preeclampsia. We further hypothesized that increased plasma homocysteine concentration during pregnancy may advance endothelial dysfunction in preeclampsia by promoting oxidative stress. STUDY
DESIGN: Antepartum blood samples were collected >/=6 hours after the last meal from 33 women with normal, uncomplicated pregnancies and from 21 women with preeclampsia. These plasma samples were analyzed for concentrations of total homocysteine; folate; triglycerides; creatinine; a marker of endothelial activation, cellular fibronectin; and a marker of oxidative stress, malondialdehyde.
RESULTS: The mean value of total plasma homocysteine in preeclampsia was significantly higher than that observed in normal pregnancy (P <. 04). Similarly, plasma malondialdehyde (P <.001), triglyceride (P <. 001), and cellular fibronectin (P <.006) concentrations were also greater in women with preeclampsia than in control subjects. However, no differences were observed between women with preeclampsia and control subjects in folate (P =.97) or creatinine (P =.28) concentrations. Homocysteine concentration did not correlate with plasma creatinine (P =.61), malondialdehyde (P =.32), or triglyceride (P =.89) concentrations. However, cellular fibronectin concentration correlated positively with homocysteine concentration in both women with preeclampsia and control subjects (r = 0.87, P <. 0001, and r = 0.50, P <.004, respectively), and folate concentrations were weakly but negatively correlated with homocysteine values (P =.03, r = 0.32).
CONCLUSIONS: Total plasma homocysteine concentration is increased in preeclampsia and is significantly correlated with cellular fibronectin concentration, suggesting that homocysteine plays a role in promoting endothelial dysfunction in preeclampsia. Furthermore, despite the use of pregnancy multivitamins and no indications of overt folate deficiency in this subject population, homocysteine concentration weakly and negatively correlates with plasma folate concentration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9855605     DOI: 10.1016/s0002-9378(98)70033-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  23 in total

Review 1.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 2.  Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia.

Authors:  Babbette D LaMarca; Jeffery Gilbert; Joey P Granger
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

3.  Evidence of endothelial dysfunction in preeclampsia and risk of adverse pregnancy outcome.

Authors:  Robert W Powers; Janet M Catov; Lisa M Bodnar; Marcia J Gallaher; Kristine Y Lain; James M Roberts
Journal:  Reprod Sci       Date:  2008-01-09       Impact factor: 3.060

4.  Autoantibodies against homocysteinylated protein in a mouse model of folate deficiency-induced neural tube defects.

Authors:  Kerina J Denny; Christina F Kelly; Vinod Kumar; Katey L Witham; Robert M Cabrera; Richard H Finnell; Stephen M Taylor; Angela Jeanes; Trent M Woodruff
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-02-22

5.  Folate metabolism gene polymorphisms MTHFR C677T and A1298C and risk for preeclampsia: a meta-analysis.

Authors:  Xiaoming Wu; Kunxian Yang; Xiaodan Tang; Yalian Sa; Ruoyu Zhou; Jing Liu; Ying Luo; Wenru Tang
Journal:  J Assist Reprod Genet       Date:  2015-03-11       Impact factor: 3.412

6.  Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis.

Authors:  Cassandra N Spracklen; Caitlin J Smith; Audrey F Saftlas; Jennifer G Robinson; Kelli K Ryckman
Journal:  Am J Epidemiol       Date:  2014-07-02       Impact factor: 4.897

7.  Hypertension in pregnancy: new recommendations for management.

Authors:  R Shear; L Leduc; E Rey; J M Moutquin
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

8.  Homocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells.

Authors:  K Schroecksnadel; B Frick; B Wirleitner; H Schennach; D Fuchs
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

Review 9.  Metabolic pathways involved in 2-methoxyestradiol synthesis and their role in preeclampsia.

Authors:  Alejandra Perez-Sepulveda; Pedro P España-Perrot; Errol R Norwitz; Sebastián E Illanes
Journal:  Reprod Sci       Date:  2013-03-01       Impact factor: 3.060

10.  Effects of hyperhomocysteinemia on arterial pressure and nitric oxide production in pregnant rats.

Authors:  Derrick L Chandler; Maria T Llinas; Jane F Reckelhoff; Babbette LaMarca; Joshua Speed; Joey P Granger
Journal:  Am J Hypertens       Date:  2009-07-23       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.